384 related articles for article (PubMed ID: 20622270)
1. [The efficacy of propafenon in the case of supraventricular atrioventricular tachycardia].
Chachua T; Abuladze G; Nebieridze M
Georgian Med News; 2010 Jun; (183):18-21. PubMed ID: 20622270
[TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
[TBL] [Abstract][Full Text] [Related]
3. [Clinical experience with propafenone in paroxysmal supraventricular reciprocating tachycardias].
Furlanello F; Vergara G; Dal Forno P; Disertori M; Inama G
G Ital Cardiol; 1984 May; 14(5):379-80. PubMed ID: 6468821
[TBL] [Abstract][Full Text] [Related]
4. [Anti-arrhythmia efficacy of propafenone per os in the prevention of paroxysmal supraventricular arrhythmia resistant to class Ia agents].
Boutaud P; Guillem JP; Maarek-Charbit M; Amiel A; Ciber M; Herpin D; Demange J
Ann Cardiol Angeiol (Paris); 1989 Jan; 38(1):37-42. PubMed ID: 2930150
[TBL] [Abstract][Full Text] [Related]
5. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
Chimienti M; Cullen MT; Casadei G
Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
Gambhir DS; Bhargava M; Arora R; Khalilullah M
Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment of young children with permanent junctional reciprocating tachycardia.
van Stuijvenberg M; Beaufort-Krol GC; Haaksma J; Bink-Boelkens MT
Cardiol Young; 2003 Oct; 13(5):408-12. PubMed ID: 14694933
[TBL] [Abstract][Full Text] [Related]
8. [Electropharmacological test with class-I C drugs in paroxysmal supraventricular re-entrant tachycardia: is a negative result with a drug predictive of the ineffectiveness of other drugs of the same class?].
Inama G; Furlanello F; Braito G; Guarnerio M; Vergara G
G Ital Cardiol; 1991 Feb; 21(2):131-8. PubMed ID: 1907937
[TBL] [Abstract][Full Text] [Related]
9. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.
Rae AP
Am J Cardiol; 1998 Oct; 82(8A):59N-65N. PubMed ID: 9809902
[TBL] [Abstract][Full Text] [Related]
10. [Drug therapy of cardiac arrhythmias 199].
Dietz A; Manz M
Fortschr Med; 1997 Nov; 115(33):32, 34-6, 38. PubMed ID: 9480278
[TBL] [Abstract][Full Text] [Related]
11. Using the right drug: a treatment algorithm for regular supraventricular tachycardias.
Lévy S; Ricard P
Eur Heart J; 1997 May; 18 Suppl C():C27-32. PubMed ID: 9152672
[TBL] [Abstract][Full Text] [Related]
12. [Efficiency of antiarrhythmic drugs of class 1C and isoptin in paroxysmal supraventricular tachycardia].
Koshumbaeva KM; Tulenov MT; Belokopit IN
Klin Med (Mosk); 2002; 80(2):57-60. PubMed ID: 11898726
[TBL] [Abstract][Full Text] [Related]
13. [The study of acute clinical electrophysiological effects of propafenone on paroxysmal supraventricular tachycardia using transesophageal atrial pacing technique].
Li Q; Wang Z; Peng D
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(2):123-6. PubMed ID: 9868052
[TBL] [Abstract][Full Text] [Related]
14. [The prospective evolution of the efficacy of antiarrhythmia therapy in paroxysmal supraventricular tachycardia in patients with the ventricular pre-excitation syndrome].
Fomina IG; Iankin VV
Klin Med (Mosk); 1992 Jan; 70(1):26-32. PubMed ID: 1608203
[TBL] [Abstract][Full Text] [Related]
15. Intravenous calcium chloride in the conversion of paroxysmal supraventricular tachycardia to normal sinus rhythm.
O'Brien JF; Tremml GP; Falk JL
Am J Emerg Med; 1996 Jan; 14(1):50-2. PubMed ID: 8630157
[TBL] [Abstract][Full Text] [Related]
16. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
Aouate P; Frank R; Fontaine G; Tonet J; Tageddine R; Benassar A; Turlure A; Jacquemin M; Laborde JP
Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1869-74. PubMed ID: 8729368
[TBL] [Abstract][Full Text] [Related]
17. Paroxysmal supraventricular tachycardia: experience with propafenone.
Santinelli V; De Paola M; Turco P; Smimmo D; Chiariello M
Angiology; 1989 Jun; 40(6):563-8. PubMed ID: 2719341
[TBL] [Abstract][Full Text] [Related]
18. [Preventive efficacy of propafenone, its effect on functional state of the heart during long-term treatment of patients with paroxysmal atrioventricular arrhythmias].
Koshumbaeva KM; Belokopit IN; Makhanov DI; Nugmanova MN
Kardiologiia; 2006; 46(11):63-5. PubMed ID: 17159883
[TBL] [Abstract][Full Text] [Related]
19. [Paroxysmal supraventricular tachycardia in pregnancy. Value of adenosine and other anti-arrhythmia agents].
Hösl P; Rust M; Johannigmann J; Schmidt G
Geburtshilfe Frauenheilkd; 1996 Jun; 56(6):313-6. PubMed ID: 8766489
[TBL] [Abstract][Full Text] [Related]
20. [Supraventricular paroxysmal tachycardias during pregnancy: the therapeutic tactics and prognosis].
Mravian SR; Petrukhin VA
Klin Med (Mosk); 2007; 85(4):17-20. PubMed ID: 17564030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
